ConductScience.org, home

Paper41575477

Palladium-catalyzed Suzuki-Miyaura and Buchwald-Hartwig cross-coupling reactions towards the synthesis of pharmacologically potent pyrimidine-based molecules.

Aman F and 6 others. Mol Divers, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Palladium-catalyzed Suzuki-Miyaura and Buchwald-Hartwig cross-coupling reactions towards the synthesis of pharmacologically potent pyrimidine-based molecules. Papers, record 41575477. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41575477

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Palladium-catalyzed Suzuki-Miyaura and Buchwald-Hartwig cross-coupling reactions towards the synthesis of pharmacologically potent pyrimidine-based molecules.
PubMed
Journal
Mol Divers
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-11-05
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Aman FFatima
2Aman LLabiqa
3Rasool NNasir
4Arshad MMahwish
5Imran MMuhammad
6Malik AAyesha
7Iqbal SSana

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References88

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121465486Transforming growth factor-beta type 1 receptor (ALK5) and Smad proteins mediate TIMP-1 and collagen synthesis in experimental intestinal fibrosis.J Pathol2011https://conductscience.org/library/papers/21465486PubMed
239094428Design and synthesis of novel Thiazolo[5,4-b]pyridine derivatives as potent and selective EGFR-TK inhibitors targeting resistance Mutations in non-small cell lung cancer.Eur J Med Chem2024https://conductscience.org/library/papers/39094428PubMed
333818764Cancer statistics for the year 2020: An overview.Int J Cancer2021https://conductscience.org/library/papers/33818764PubMed
435884170Novel 1,2,3-Triazole-sulphadiazine-ZnO Hybrids as Potent Antimicrobial Agents against Carbapenem Resistant Bacteria.Antibiotics (Basel)2022https://conductscience.org/library/papers/35884170PubMed
537659145Design and synthesis of 1H-pyrazolo[3,4-d]pyrimidine derivatives as hematopoietic progenitor kinase 1 (HPK1) inhibitors.Bioorg Chem2023https://conductscience.org/library/papers/37659145PubMed
627670581Roles of Pyridine and Pyrimidine Derivatives as Privileged Scaffolds in Anticancer Agents.Mini Rev Med Chem2017https://conductscience.org/library/papers/27670581PubMed
732208930Cyclin-dependent kinase 7 inhibitors in cancer therapy.Future Med Chem2020https://conductscience.org/library/papers/32208930PubMed
837738768Pyrimidine-morpholine hybrids as potent druggable therapeutics for Alzheimer's disease: Synthesis, biochemical and in silico analyses.Bioorg Chem2023https://conductscience.org/library/papers/37738768PubMed
919116299Current concepts in Alzheimer's disease: a multidisciplinary review.Am J Alzheimers Dis Other Demen2009https://conductscience.org/library/papers/19116299PubMed
1028174091Inhibitors of cyclin-dependent kinases as cancer therapeutics.Pharmacol Ther2017https://conductscience.org/library/papers/28174091PubMed
1137086581Design, synthesis, and biological evaluation of pyrido[3,2-d]pyrimidine derivatives as novel ATR inhibitors.Bioorg Chem2023https://conductscience.org/library/papers/37086581PubMed
1226777239Rapamycin-induced oligomer formation system of FRB-FKBP fusion proteins.J Biosci Bioeng2016https://conductscience.org/library/papers/26777239PubMed
1340479644Metal-N-Heterocyclic Carbene Complexes in Buchwald-Hartwig Amination Reactions.Chem Rev2025https://conductscience.org/library/papers/40479644PubMed
1422825331The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy.Cancer Biol Ther2012https://conductscience.org/library/papers/22825331PubMed
1536851791HIV and COVID-19 Co-Infection: Epidemiology, Clinical Characteristics, and Treatment.Viruses2023https://conductscience.org/library/papers/36851791PubMed
1639561494Design, synthesis, and structure-activity relationship studies of triazolo-pyrimidine derivatives as WRN inhibitors for the treatment of MSI tumors.Eur J Med Chem2025https://conductscience.org/library/papers/39561494PubMed
1717072348ALK5 promotes tumor angiogenesis by upregulating matrix metalloproteinase-9 in tumor cells.Oncogene2007https://conductscience.org/library/papers/17072348PubMed
1831991322Synthesis, molecular docking and antimicrobial activity of new fused pyrimidine and pyridine derivatives.Bioorg Chem2020https://conductscience.org/library/papers/31991322PubMed
1922339650Biology and significance of the JAK/STAT signalling pathways.Growth Factors2012https://conductscience.org/library/papers/22339650PubMed
2032150405CDK7 Inhibitors in Cancer Therapy: The Sweet Smell of Success?J Med Chem2020https://conductscience.org/library/papers/32150405PubMed

See all 88 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41575477

GET https://conductscience.org/api/papers/v1/41575477/references?page=2